Announcements Trials

Browse Landscape

Phase

Status

Recruiting 33 Active not recruiting 16 Not yet recruiting 6 Suspended 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 33 Carboplatin 18 Cisplatin 15 Nivolumab 14 Pemetrexed 12 Paclitaxel 12 Ipilimumab 11 atezolizumab 10 Gemcitabine 10 venetoclax 9 Radiotherapy 9 Docetaxel 9 durvalumab 8 Cyclophosphamide 8 fludarabine 7 Specimen Handling 7 Biopsy 7 Bevacizumab 7 tislelizumab 6 enzalutamide 6 Trastuzumab 6 Practice Guidelines as Topic 6 Cetuximab 6 tazemetostat 5 fludarabine phosphate 5 Surveys and Questionnaires 5 Standard of Care 5 Radiosurgery 5 Magnetic Resonance Spectroscopy 5 Injections 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × trastuzumab deruxtecan × 90 days × Clear all

NCT05744375 2026-04-02

TRANSCENDER

Spanish Breast Cancer Research Group

Phase 2 Terminated

2 enrolled 10 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡